Wellington Intensive Care Unit

Te Rui Atawhai

Medical Research Institute New Zealand
The unit participates in multi-centre & multi-national clinical trials that we believe will benefit both our patients and the advancement of knowledge in Intensive Care Medicine.

All trials that we participate in have prior Ethics Committee approval and trial participation is only by agreement of all the Senior Medical Staff.

The research nursing team work within the unit to ensure that data collection is accurate and that trial enrolment and treatment protocols are adhered to.

The research team have produced a brochure providing information for patients & their families.
This can be downloaded using the button to the right. Please ask a member of the research nursing team if would like a printed copy.

Intensive Care Foundation

The Intensive Care Foundation is a charitable organisation formed by ANZICS in 1990. It works to raise money in New Zealand & Australia to improve the care of critically ill patients through research & the education of health professionals responsible for intensive care. More information on the vital work they do can be found by clicking the logo to the left.

Wellington Regional Hospital also has a Clinical Trials Unit, a dedicated clinical research facility funded by Capital & Coast District Health Board. The 14-bed unit is the first to be located in a New Zealand public hospital with access to a wide range of clinical specialists & networks.

Clinical Trials Unit

Please select the logo above for more information.

If you are a staff member of Wellington ICU looking for more information on current or upcoming trials, please use the button to the right or the menu bar at the top of the page.

  • normal Saline vs PLasmalyte in Intensive care Therapy
  • HyperOxaemic Therapy or NormOxaemic Therapy in patients after cardiac arrest
  • New Zealand Medical Emergency Team activation
  • permissive HyperthErmiA Through avoidance of paracetamol in known or suspected infection in ICU
  • Proton pump inhibitors vs histamine-2 rEceptor blockers for ulcer Prophylaxis Therapy in the Intensive Care
The CHEST trial: Crystalloid versus Hydroxy-Ethyl Starch
The DECRA trial: Early decompressive craniectomy in patients with severe traumatic brain injury
The NICE-SUGAR trial: Intensive versus conventional glucose control in critically ill patients
The EARLY PN trial: Early parenteral nutrition vs standard care in the critically ill patient
The RIPS trial: Remote ischaemic preconditioning in cardiac surgery
The RIPS Dose trial: defining the optimal dose for remote ischaemic preconditioning in cardiac surgery
DARE: Discharge And Readmission Evaluation Study
SPICE: Sedation Practices in Intensive Care
INFINITE Influenza A Registry
The HOTorNOT trial
The DahLIA trial: Dexmedetomidine to Lessen ICU Agitation
The BLING2 trial: continuous vs intermittent beta-lactam dosing in critically ill patients
The HEAT trial: Permissive HyperthErmiA Through avoidance of Paracetamol in sepsis trial
Relative’s and staff’s experience of the moment of death in the Intensive Care Unit
The SPLIT trial: Normal Saline vs Plasma-Lyte in Intensive Care patients
The EPO-TBI trial: Erythropoietin in Traumatic Brain Injury
The TEAM trial: early activity & mobility in ventilated ICU patients
The ICON audit: an audit of international ICU practice
The NZMET study: characteristics & outcomes of Medical Emergency Team calls in New Zealand hospitals
The ZORO trial: Intravenous Zanamivir versus Oral Oseltamivir in Adults with Influenza
The PHARLAP trial: Permissive Hypercapnia, Alveolar Recruitment & Limited Airway Pressures in ventilated patients with ARDS

Wellington ICU endorses the Trial Acronym Generator

This page was last updated on Friday, 01 June 2018 13:14:56

ICU Research Poster